• At Pharmaceutical Specialties, Inc. patient care comes first.
register. PSI notification system
Register
Patients are strongly encouraged to register for PSI’s state-of-the-art Drug Therapy Notification System. This system is the safest way to ensure that you receive critical notifications on when to receive your next dosage of a therapy.

The system simultaneously sends voice messages to registered telephones, text messages to cell phone, PDA, iPhone Android, and essentially any other text-message capable phones, as well as an e-mail message to your email account to alert you of information critical to your safety and well-being. To take advantage of this automated service and register your automated notifications, complete the registration to the right on this page.

Please note your wireless service provider may charge a nominal fee for receiving text messages. Review Drug Therapy Notification System Terms and Conditions.


notification system. register
  • Notifications: Available Therapies
    Select the Drug Therapy you are subscribing to:
  • Drug Therapy Dosage Information
    Select the date and time of your next drug therapy dosage:

    Indicate the doses remaining for your selected drug therapy:
  • Agree to the Terms and Conditions:
    Select the box to agree to the Terms and Conditions of this service:
    *

    Note: to participate in these services, you may be charged a fee to send and receive SMS text messages based on the terms of your wireless service agreement with your wireless service provider. Other charges may also apply. All charges are billed by and payable to your wireless service provider. Check your wireless service provider if you have questions about your service plan.

  • Notification Delivery:
    Enter requested information for each delivery method you wish to subscribe to:




    Leave the corresponding cell blank if you do not want to utilize the indicated notification delivery method.

    * This information has been utilized by a previous registrant. Please try again. If you feel this notification is incorrect please contact CustomerSupport@PSIPharmaceuticals.com for further assistance.
  • Review and Confirm
    The following is a summary of the information you have provided for your subscription to the PSI Notification System. Please review all information for accuracy and then confirm your subscription by clicking the Submit button. 
    
			
    
		
    • 
		
  • 
			
    
				Processing...
    
			
    
				Please wait while your request is processed...
			
    
		
    • 
		
  • 
			
    
				Thank You
    
			
    
				Your subscription registration has been completed!
			
    
			
    
				
    
					We have sent a welcome message at each of the delivery methods you selected in the
					registration process. If you do not receive a welcome message at each of these methods
					shortly please contact CustomerSupport@PSIPharmaceuticals.com.
    
				
    
					Thank you,
    
				
			
    
		
    • 
	

	

		

			*  Required

		
			
				




				

			

		

			

				

					Register - LL Banner

				

			

				

					
					
We also offer patients a variety of other medications specially designed for cystic fibrosis patients, including:


    
    
  • 
    >  Preservative free unit dosed tobramycin for nebulization in eFlow ® nebulizer
    
    • 
    
  • 
    >  Pulmozyme ®
    
    • 
    
  • 
    >  TOBI ®
    
    • 
    
  • 
    >  SourceCF Softgel High Potency Adult Multivitamins softgels, chewables, and drops
    
    • 
    
  • 
    >  Hypertonic Saline 3%, 5%, 7% including Hyper Sal by PARI
    
    • 
    
  • 
    >  Colistimethate
    
    • 
    
  • 
    >  Xopenex ®
    
    • 
    
  • 
    >  Pancreatic enzymes
    
    • 
    
  • 
    >  Antibiotics
    
    • 
    
  • 
    >  Many more
    
    • 



For more information on our cystic fibrosis treatment options, contact us today. 


*Disclaimer: The eFlow® nebulizer has not undergone human clinical studies to determine its safety or efficacy and has not been approved by the FDA for use with tobramycin in the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis. Compounded prescriptions are not evaluated by the FDA for safety or efficacy.


				
				

			

		

			

				

					
the latest. news


				
				

			

				

					


					

Bringing the pieces together......





Pharmaceutical Specialties, Inc.
approved by Wellcare of Georgia to provide Cayston to Wellcare Medicaid of GA recipients.

        

        http://georgia.wellcare.com/

        Georgia Wellcare, January 15, 2011




				
Pharmaceutical Specialties, Inc. is supporting the Pediatric Nurses Society and attending the National Meeting in Orlando in April.

Pharmaceutical Specialties, Inc. recently attended the Annual Liver Symposia at Duke Medical Center.